Identification of hepatitis B virus aetiologic antigens, HBx and Pre-S2, in diffuse large B-cell lymphoma

J Viral Hepat. 2020 Sep;27(9):948-950. doi: 10.1111/jvh.13301. Epub 2020 Apr 28.

Abstract

Diffuse large B-cell lymphoma (DLBCL) has been reported to have a significant association with the hepatitis B virus (HBV) infection. However, there has been no experimental evidence to determine whether the components of the hepatitis B virus are expressed in lymphoid cells. In this study, we used immunohistochemical methods to explore whether the antigens of hepatitis B virus are expressed in DLBCL lymphoma cells in HBsAg-positive DLBCL patients (HBsAg + DLBCL). HBx antigen was detected in 48.9% of HBsAg + DLBCL patients, and the expression rate of the Pre-S2 antigen was 57.2%. HBx expression was significantly associated with high-level expression of c-Myc, while the Pre-S2 antigen was not. In this study, we demonstrated that HBx antigen and Pre-S2 antigen could be detected in lymphoma cells, and HBx expression was related to c-Myc expression. Our findings provide a strong basis for further study of the HBV-infected DLBCL and molecular mechanism underlying the lymphomagenesis.

Keywords: DLBCL; HBx; hepatitis B virus antigens; immunohistochemistry; pre-S2.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Hepatitis B Surface Antigens / analysis*
  • Hepatitis B virus
  • Hepatitis B* / complications
  • Humans
  • Lymphoma, Large B-Cell, Diffuse* / virology
  • Trans-Activators / analysis*
  • Viral Regulatory and Accessory Proteins / analysis*

Substances

  • Hepatitis B Surface Antigens
  • Trans-Activators
  • Viral Regulatory and Accessory Proteins
  • hepatitis B virus X protein